Today we take a look at Ford’s recent run of good fortune and forecast what could come next for the stock. We also feature a reader letter about wages and the free market.
We think an ETF pegged exclusively to meme stocks must be in the works. We’re calling it now…
Novavax announced its Covid-19 vaccine… So what’s next for the Maryland-based biotech company?
The Senate passed the U.S. Innovation and Competition Act (USICA). The bill aspires to make America competitive again… and takes aim at China.
“This could be a key moment for the biotech sector,” says our chief market analyst Greg Guenthner.
Small businesses -- hanging on by a thread -- are being taxed for pandemic shortfalls…
“Trump and Biden don’t agree on much,” says our tech expert Ray Blanco. “So what’s bringing together both sides of the aisle?”
Over the past 15 months, pharmaceutical companies have become keenly aware of China’s dominance…
“How do you know when stocks are becoming too risky?” asks retirement specialist Zach Scheidt.
Marijuana stocks are coming in hot this year with upward momentum from strong revenue.